Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03241303
What this trial is testing

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Who this might be right for
Glucose Metabolism Disorders
University Hospital, Gentofte, Copenhagen 15
Not applicableStudy completedNCT00817973
What this trial is testing

Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein

Who this might be right for
Type 2 DiabetesPostprandial Lipemia
Aarhus University Hospital 12
Not applicableStudy completedNCT07097987
What this trial is testing

Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion

Who this might be right for
Obesity
TCI Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT01514149
What this trial is testing

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
ConjuChem 73
Post-approval studies (Phase 4)Study completedNCT01911468
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 36
Post-approval studies (Phase 4)Study completedNCT02621489
What this trial is testing

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

Who this might be right for
AtherosclerosisDiabetesRestenosis
Karolinska Institutet 38
Not applicableLooking for participantsNCT06487832
What this trial is testing

Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness

Who this might be right for
Normal WeightOverweight and ObesityInsulin Sensitivity+1 more
University Hospital Tuebingen 60
Post-approval studies (Phase 4)Study completedNCT01899430
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 32
Early research (Phase 1)Study completedNCT00813228
What this trial is testing

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

Who this might be right for
Diabetes Mellitus Type 1Diabetes Mellitus Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 76
Not applicableStudy completedNCT06660134
What this trial is testing

Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Atrial Fibrillation (AF)
Shanghai Chest Hospital 174
Post-approval studies (Phase 4)Looking for participantsNCT04575844
What this trial is testing

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
University of Virginia 80
Not applicableNot Yet RecruitingNCT07276763
What this trial is testing

Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention

Who this might be right for
Gastric Retention
Fudan University 16,509
Not applicableStudy completedNCT01413126
What this trial is testing

Peanuts Second Meal Glycemic Response

Who this might be right for
Type 2 Diabetes Mellitus
Federal University of Vicosa 15
Testing effectiveness (Phase 2)Study completedNCT06621017
What this trial is testing

Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects

Who this might be right for
Obesity; Overweight
Rose Pharma Inc 40
Post-approval studies (Phase 4)Study completedNCT02014740
What this trial is testing

Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesOverweightObesity
University of Miami 100
Not applicableStudy completedNCT02185638
What this trial is testing

Appetite Suppression Effects of an Herbal Combination of Yerba maté, Guarana, Damiana (YGD), and 12 Other Herbal Components, Versus YGD Supplementation Alone

Who this might be right for
Obesity
University of Copenhagen 19
Post-approval studies (Phase 4)Study completedNCT02465515
What this trial is testing

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
GlaxoSmithKline 9,463
Testing effectiveness (Phase 2)UnknownNCT05659368
What this trial is testing

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Who this might be right for
Wolfram Syndrome
Ospedale San Raffaele 10
Post-approval studies (Phase 4)Study completedNCT01664676
What this trial is testing

Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
University of Aarhus 11
Not applicableLooking for participantsNCT07484061
What this trial is testing

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Who this might be right for
Telogen Effluvium
Olistic Research Labs S.L. 40
Next Page